Page 1

Title: At a CAGR of 7.82%, Global and China Drugs for Treatment of Non-small-Cell Lung Cancer Research Report to 2020, Key Players and Emerging Growth Short Summary Global and China Drugs for Treatment of Non-small-Cell Lung Cancer Research Report to 2020 Size and Share Published in 2016-06-17 Available for US$ 2550 at Researchmoz.us Description The global Drugs for Treatment of Non-small-Cell Lung Cancer market was valued at USD 74.8 Billion in 2015, and is projected to reach USD 109 Billion by 2021, at a CAGR of 7.82% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs This report studies Drugs for Treatment of Non-small-Cell Lung Cancer in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Japan, Western Europe, Japan and China, forecast to 2020, from 2015. Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering Avastin Afatinib Pemetrexed Erlotinib Paclitaxel Compound cantharidin capsule Gefitinib Apa imatinib Crizotinib Docetaxel S-1 Doxorubicin Gemcitabine Javanica oil soft capsule Tagrisso


Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php? type=S&repid=737251

Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Non-small-Cell Lung Cancer, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering Roche Boehringer Ingelheim GmbH Eli lily Celgene AstraZeneca Pfizer Sanofi Taiho Johnson Qilu Pharmaceutical

Split by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Western Europe, Japan and China, from 2011 to 2020 (forecast), covering US Western Europe Japan China With 210pages, 178 charts and eight chapters, to display the market present situation and future, clearly and deeply.

Inquiry on this report: http://www.researchmoz.us/enquiry.php? type=E&repid=737251

Table of Content 1 Drugs for Treatment of Non-small-Cell Lung Cancer Overview and Each Type 1.1 Product Overview of Drugs for Treatment of Non-small-Cell Lung Cancer


1.1.1 Definition and Product Scope of Drugs for Treatment of Non-small-Cell Lung Cancer 1.1.2 Global Market Size (Value and Volume) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020 1.1.3 China Market Size (Value and Volume) of Drugs for Treatment of Non-small-Cell Lung Cancer 2015-2020 1.2 Product Segments and Price of Each Type 1.2.1 Product Type of Key Manufacturers 1.2.2 Price List of Each Type in 2015 to 2016 1.2.3 Market Share and Growth Rate of Each Type 1.2.4 Avastin Specification and Price in 2015 and 2016 1.2.5 Afatinib Specification and Price in 2015 and 2016 1.2.6 Pemetrexed Specification and Price in 2015 and 2016 1.2.7 Tarceva Specification and Price in 2015 and 2016 1.2.8 Paclitaxel Specification and Price in 2015 and 2016 1.2.9 Compound cantharidin capsule Specification and Price in 2015 and 2016 1.2.10 Gefitinib Specification and Price in 2015 and 2016 1.2.11 Apa imatinib Specification and Price in 2015 and 2016 1.2.12 Crizotinib Specification and Price in 2015 and 2016 1.2.13 Docetaxel Specification and Price in 2015 and 2016 1.2.14 S-1 Specification and Price in 2015 and 2016 1.2.15 Doxorubicin Specification and Price in 2015 and 2016 1.2.16 Gemcitabine Specification and Price in 2015 and 2016 1.2.17 Javanica oil soft capsule Specification and Price in 2015 and 2016 1.2.18 Tagrisso Specification and Price in 2015 and 2016 1.3 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016 1.3.1 Price List (Interviewed) of Avastin by Key Manufacturers 1.3.2 Price List (Interviewed) of Afatinib by Key Manufacturers 1.3.3 Price List (Interviewed) of Pemetrexed by Key Manufacturers 1.3.4 Price List (Interviewed) of Tarceva by Key Manufacturers 1.3.5 Price List (Interviewed) of Paclitaxel by Key Manufacturers 1.3.6 Price List (Interviewed) of Compound cantharidin capsule by Key Manufacturers 1.3.7 Price List (Interviewed) of Gefitinib by Key Manufacturers 1.3.8 Price List (Interviewed) of Apa imatinib by Key Manufacturers


1.3.9 Price List (Interviewed) of Crizotinib by Key Manufacturers 1.3.10 Price List (Interviewed) of Docetaxel by Key Manufacturers 1.3.11 Price List (Interviewed) of S-1 by Key Manufacturers 1.3.12 Price List (Interviewed) of Doxorubicin by Key Manufacturers 1.3.13 Price List (Interviewed) of Gemcitabine by Key Manufacturers 1.3.14 Price List (Interviewed) of Javanica oil soft capsule by Key Manufacturers 1.3.15 Price List (Interviewed) of Tagrisso by Key Manufacturers

2 Competition Analysis by Manufacturers in Global and China 2.1 Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales and Share List of Key Manufacturers 2015 to 2016 2.2 Global Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue and Share List of Key Manufacturers 2015 to 2016 2.3 Global Drugs for Treatment of Non-small-Cell Lung Cancer Average Price List of Key Manufacturers 2015 to 2016 2.4 China Market Drugs for Treatment of Non-small-Cell Lung Cancer Sales and Share List of Key Manufacturers 2015 to 2016 2.5 China Market Drugs for Treatment of Non-small-Cell Lung Cancer Revenue and Share List of Key Manufacturers 2015 to 2016 2.6 China Drugs for Treatment of Non-small-Cell Lung Cancer Average Price List of Key Manufacturers 2015 to 2016

Browse All Medical Equipments Market Research Reports at: http://www.researchmoz.us/medical-equipments-market-reports-109.html

About ResearchMoz ResearchMoz   is   the   world’s   fastest   growing   collection   of   market   research reports worldwide. Our database is composed of current market studies from over   100   featured   publishers   worldwide.   Our   market   research   databases integrate statistics with analysis from global, regional, country and company perspectives.  Contact Us: ResearchMoz Mr. Nachiket Ghumare, +1-518-621-2074 USA-Canada Toll Free: 866-997-4948


sales@researchmoz.us http://www.researchmoz.us/

Global and china drugs for treatment of non small cell lung cancer research report to 2020  
Read more
Read more
Similar to
Popular now
Just for you